KACTUS Publishes Framework for 2+1 and Trispecific TCE Scaffold Design
KACTUS has published a technical framework for engineering 2+1 and trispecific T-cell engager therapeutics, addressing structural scaffold challenges for drug discovery teams advancing beyond conventional bispecific formats. Waltham, Massachusetts, United States, April 23, 2026 —… Read More »KACTUS Publishes Framework for 2+1 and Trispecific TCE Scaffold Design





